Forsta AP Fonden Boosts Position in Healthpeak Properties, Inc. (NYSE:DOC)

Forsta AP Fonden increased its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 98.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 443,800 shares of the real estate investment trust’s stock after buying an additional 220,700 shares during the quarter. Forsta AP Fonden owned 0.06% of Healthpeak Properties worth $8,996,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. JPMorgan Chase & Co. increased its position in Healthpeak Properties by 23.2% in the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock worth $493,115,000 after buying an additional 4,056,931 shares in the last quarter. Thrivent Financial for Lutherans purchased a new stake in Healthpeak Properties in the 3rd quarter worth approximately $1,880,000. Swedbank AB bought a new stake in Healthpeak Properties during the 3rd quarter worth approximately $1,832,000. Pathstone Holdings LLC purchased a new position in Healthpeak Properties during the third quarter valued at approximately $1,968,000. Finally, Associated Banc Corp bought a new position in shares of Healthpeak Properties in the third quarter worth approximately $10,559,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on DOC shares. Wells Fargo & Company dropped their price objective on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 10th. Robert W. Baird increased their price objective on shares of Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. StockNews.com cut Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Wednesday, October 30th. Morgan Stanley raised shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective for the company in a research note on Wednesday, January 15th. Finally, Royal Bank of Canada upped their price target on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a report on Monday, November 4th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Healthpeak Properties presently has a consensus rating of “Moderate Buy” and a consensus target price of $24.15.

Healthpeak Properties Stock Up 1.6 %

Shares of Healthpeak Properties stock opened at $20.53 on Friday. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.93. The company has a market cap of $14.36 billion, a P/E ratio of 43.67, a PEG ratio of 2.21 and a beta of 1.14. The firm’s 50 day moving average price is $20.79 and its 200-day moving average price is $21.55. Healthpeak Properties, Inc. has a 52-week low of $16.01 and a 52-week high of $23.26.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.